Heterogeneity in reductions in transmission: Changes in seroconversion rates for anti <i>P.falciparum</i> AMA-1 antibody responses, in <i>P.falciparum</i> prevalence and in under five mortality before and after interventions by region.

1<p>from 2004 and 2008 surveys respectively.</p

Median anti- <i>P.falciparum</i> AMA-1 antibody titres by age group by region.

<p>Median anti- <i>P.falciparum</i> AMA-1 antibody titres by age group by region.</p

Numbers and prevalence for Rapid Diagnostic Test and anti <i>P.falciaprum</i> AMA-1 antibody positive individuals for each sentinel site in Bioko.

<p>Numbers and prevalence for Rapid Diagnostic Test and anti <i>P.falciaprum</i> AMA-1 antibody positive individuals for each sentinel site in Bioko.</p

Demographic characteristics of the study population.

1<p>- within the previous 6 months.</p>2<p>- on the night before the survey.</p><p>**Moca and Musola kept separate due to their high altitude.</p

MOESM1 of Use of mobile technology-based participatory mapping approaches to geolocate health facility attendees for disease surveillance in low resource settings

Additional file 1. Example questionnaire and associated data types

MÉXICO: LOS RETOS DE UN TRÁNSITO A LA DEMOCRACIA

No tien

Univariate profile likelihood to evaluate the time at which sero-conversion rates changed.

<p>Same region fits are represented in a) for MSP-1₁₉ fits and b) for AMA-1. The broken black line is the 95^th percentile of the Chi-squared on 1 degree of freedom below the maximum. The two points at which this line crosses the log-likelihood profile are used to determine an approximate 95% confidence interval for the time since the change in SCR i.e. 11–18 years for MSP-1₁₉ and 6 to 14 years for AMA-1. The equivalent plots for Korogwe are shown in c) for MSP-1₁₉ and d) for AMA-1.</p

Current sero-conversion rates and clinical malaria incidence rates in the IPTi placebo cohort for each health facility: (a) for MSP-1₁₉ and (b) for AMA-1.

<p>Vertical bars indicate the 95% CI for SCR and horizontal bars indicate the 95% CI for malaria incidence. Fitted lines represent linear regression plots. R² values for MSP-1₁₉ and AMA are 0.78 and 0.91, respectively.</p

Sero-conversion rates for MSP-1₁₉ and AMA-1 by district and by individuals attending the health facility as health seekers or as companions.

<p>Sero-conversion rates for MSP-1₁₉ and AMA-1 by district and by individuals attending the health facility as health seekers or as companions.</p

Age distribution, RDT positivity and serological responses to both MSP-1₁₉ and AMA-1 of patients recruited through cross-sectional and health facility surveys in Msitu wa Tembo.

<p>The median titre and interquartile range (IQR) were presented.</p>*<p>denotes a significant difference in the median values tested by ranksum analysis.</p